1240427-94-4Relevant articles and documents
POTENT AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS
-
, (2012/03/26)
The present invention is directed to compounds, compositions and methods for treating or preventing hepatitis C virus (HCV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and othe
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 53, (2012/04/10)
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds
DIARYL ETHERS
-
Page/Page column 26, (2010/11/05)
Compounds of the formula (I): including any possible stereoisomers thereof, or a pharmaceutically acceptable salt and/or solvate thereof, as well as pharmaceutical formulations and the use of compounds of formula I as HCV inhibitors.